US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ヨーロッパ
EU
Diagnostic Medical Systems (ALDMS) 銘柄情報

Diagnostic Medical Systems (ALDMS)

1.28

-0.015

(-1.16%)

終了 6月14日 12:30AM

Diagnostic Medical Systems (ALDMS) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

1.28

( -1.16% )

買値

1.28

売値

1.295

出来高

12,710

1.28 日の範囲 1.305

1.17 52 週間の範囲 1.485

時価総額

前日終値

1.295

始値

1.285

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

14,182 €

発行済株式数

25,898,881

配当利回り

PER

-16.69

1 株当たり利益 (EPS)

-0.07

歳入

49.47M

純利益

-1.67M

Diagnostic Medical Systems S.A. designs, develops, manufactures, and sells medical imaging systems in France. The company offers ADAM, a software suite for imaging experts; R and F solutions, including Platinum Neo, Platinum Flex, and Optima; bone densitometers, including Stratos and Medix Series; M... Diagnostic Medical Systems S.A. designs, develops, manufactures, and sells medical imaging systems in France. The company offers ADAM, a software suite for imaging experts; R and F solutions, including Platinum Neo, Platinum Flex, and Optima; bone densitometers, including Stratos and Medix Series; MISTRAL, a manual chest and bone solution; and Camargue series which offers motorized radiographic systems to perform all types of bone and chest exams, including full spine and long leg exams. It also provides mobiles under the !M1, ONYX, Rafale/Rafale DR, and !Mobile Wall Stand names; c-arm products under the EVO R+ FP ADAM and EVO + / EVO R+ names; retrofit kits; and mammography equipment. The company was founded in 1979 and is headquartered in Gallargues-le-Montueux, France. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.dms-imaging.com

本社

Gallargues-le-montueux, France

設立

1979

Diagnostic Medical Systems is listed in the Healthcare sector of the ユーロネクスト with ticker ALDMS. The last closing price for Diagnostic Medical Systems was 1.30 €. Over the last year, Diagnostic Medical Systems shares have traded in a share price range of 1.17 € to 1.485 €.

Diagnostic Medical Systems currently has 25,898,881 shares in issue. The market capitalisation of Diagnostic Medical Systems is 33.15 € million. Diagnostic Medical Systems has a price to earnings ratio (PE ratio) of -16.69.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.05	4.06504065041	1.23	1.315	1.22	18194	1.27002789	DE
4	-0.04	-3.0303030303	1.32	1.32	1.22	12606	1.2603373	DE
12	-0.035	-2.66159695817	1.315	1.4	1.22	16016	1.31794544	DE
26	0.05	4.06504065041	1.23	1.485	1.22	18273	1.34422771	DE
52	0.11	9.40170940171	1.17	1.485	1.17	20063	1.34604171	DE
156	-0.245	-16.0655737705	1.525	1.53	0.64	14346	1.15072965	DE
260	0.12	10.3448275862	1.16	1.6	0.64	12834	1.16153999	DE

ALDMS - Frequently Asked Questions (FAQ)

What is the current Diagnostic Medical Systems share price?

The current share price of Diagnostic Medical Systems is 1.28 €

How many Diagnostic Medical Systems shares are in issue?

Diagnostic Medical Systems has 25,898,881 shares in issue

What is the market cap of Diagnostic Medical Systems?

The market capitalisation of Diagnostic Medical Systems is EUR 33.15M

What is the 1 year trading range for Diagnostic Medical Systems share price?

Diagnostic Medical Systems has traded in the range of 1.17 € to 1.485 € during the past year

What is the PE ratio of Diagnostic Medical Systems?

The price to earnings ratio of Diagnostic Medical Systems is -16.69

What is the cash to sales ratio of Diagnostic Medical Systems?

The cash to sales ratio of Diagnostic Medical Systems is 0.64

What is the registered address of Diagnostic Medical Systems?

The registered address for Diagnostic Medical Systems is 9 Avenue du Canal Philippe Lamour, Gallargues-le-Montueux, Languedoc-Roussillon, 30 660

What is the Diagnostic Medical Systems website address?

The website address for Diagnostic Medical Systems is www.dms-imaging.com

Which industry sector does Diagnostic Medical Systems operate in?

Diagnostic Medical Systems operates in the Medical Equipment & Supplies sector

EZ2

11-12-22-24. 🙏

FlashySage44

FlashySage44 15分前

The day of reckoning is coming.
Two and a half weeks until the Next ER.
8 and a half until the August one.
No buyout in sight.
When will the longs start to question the buyout not happening?
I am very interested to see what this place will be saying come September

FlashySage44

FlashySage44 33分前

You’re not wolv?

jay_tee

jay_tee 50分前

That “yup still there” has to be the most asinine post ever. Where else would worthless paper/digital em shares be? Sure the shares are there BUT Seamus has taken its value and poured it into FOXO. He played us all well at least up to this point….safe shares sitting at .000001 is toilet paper

doogdilinger

doogdilinger 59分前

Right place at the right time BERK buddy:

joe_techi

joe_techi 1時間前

The Rolling Stones - 2000 Light Years From Home
https://www.youtube.com/watch?v=RLhFT7YXnoI

xoom

xoom 1時間前

Exactly. Please ask your bosses to distribute shares asap..
Please ask your bosses to learn from Musk and how he treats his folks aka SpaceX shareholders.

Frankestin

Frankestin 1時間前

https://youtu.be/iH3oOVKt0WI?is=6VNcgxb-14JC0yZD

gregcod

gregcod 1時間前

Is july going to be IBATs Month?

rodeoup

rodeoup 2時間前

Spot on. This will be the best summer this company has ever had in my book!!!

Dragonman1

Dragonman1 2時間前

please send me the email

satter

satter 3時間前

Unless he is going to announce he is receiving some major investment, capital, nothing is going to change. Eric will just make it sound like some big change coming with his master of loaded words. And unfortunately once again you'll fall for it. Even after Eric mislead, misrepresented, again, how gr

US Market News

US Market News 3時間前

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLLJune 14, 2026 3:15 AM
PR Newswire (US) BRUIN C

eagle8

eagle8 3時間前

Andrew Caravello, DO reposted
RJM
@rjmsoflo
The Day After Approval

Strategically Dangerous

$NWBO

What does NWBO look like to serious money the day after approval?

Because right now… the market sees OTC, delays, dilution

t1215s

t1215s 3時間前

Good morning people, There are. Others that could use that monies without a doubt for whatever their needs are , As for me ,I never really counted on it,hence my iffen on topic of returns , but I sure as heck would enjoying spending it and giving some away for sure ,as my life is just fine the way

Investor2014

Investor2014 4時間前

Terrie should go for $1249 and call it quits.

Tr8dervic

Tr8dervic 4時間前

I'm in with 5 11 24 19

Dave has 5 24 19 11

Waiting on Stephen

mrwrn2010

mrwrn2010 4時間前

“WHEREAS, Elite Laboratories, Inc., intends to amend ANDA No. 217939…”

I take that to mean they are just flipping to P3 and not starting from scratch. Question is how much review has the FDA done on this ANDA to date? And does the 30-month stay only affect final approval, or does it b

europa7

europa7 4時間前

Dell Technologies to Bring Grok SpaceXAI Models On-Premises to Enterprise Environments
"...Dell and SpaceXAI bring Grok AI models on-premises, giving enterprises advanced AI with complete data control and security..."
May 18, 2026
https://www.dell.com/en-us/blog/dell-technologie

Just give me $1.50

Just give me $1.50 4時間前

Does anybody know the answer to this question?

1. Does Elite have to submit a brand new Paragraph 3 filing for Generic OxyContin, meaning they'll have to wait the full 10 months for a Tentative Approval. Or can we just switch it from Paragraph 4 to Paragraph 3 with someone paperwor

Just give me $1.50

Just give me $1.50 5時間前

1. How do you know that isn't standard boilerplate language? In other words, every company in the same/similar situation does the exact same thing. Similar to 10-K's for publicly traded companies, literally every possible scenario and warning is listed in there.

2. What are the

barnstormer

barnstormer 5時間前

082, if she had ever said that there would be a record somewhere on file. You're good at making up supposed statements but as usual when pushed for support of your statement there isn't anything to be found. That's pretty par for the course with your act. Make up a story or accusation without suppor

Diagnostic Medical Systems

Iino Kaiun Kaisha (PK)

Bmo Concentrated Global ...

FNP Technologies

Semco Technologies

West Pharmaceutical Serv...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。